erlotinib hydrochloride has been researched along with hymecromone in 1 studies
Studies (erlotinib hydrochloride) | Trials (erlotinib hydrochloride) | Recent Studies (post-2010) (erlotinib hydrochloride) | Studies (hymecromone) | Trials (hymecromone) | Recent Studies (post-2010) (hymecromone) |
---|---|---|---|---|---|
4,353 | 786 | 3,033 | 1,241 | 18 | 323 |
Protein | Taxonomy | erlotinib hydrochloride (IC50) | hymecromone (IC50) |
---|---|---|---|
Testosterone 17-beta-dehydrogenase 3 | Homo sapiens (human) | 1 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
House, L; Liu, Y; RamÃrez, J; Ratain, MJ | 1 |
1 other study(ies) available for erlotinib hydrochloride and hymecromone
Article | Year |
---|---|
Comparison of the drug-drug interactions potential of erlotinib and gefitinib via inhibition of UDP-glucuronosyltransferases.
Topics: Adolescent; Adult; Aged; Area Under Curve; Bilirubin; Binding, Competitive; Biocatalysis; Cell Line; Child; Drug Interactions; Erlotinib Hydrochloride; Female; Gefitinib; Glucuronic Acid; Glucuronosyltransferase; Humans; Hymecromone; Imipramine; Indinavir; Isoenzymes; Kinetics; Male; Microsomes, Liver; Middle Aged; Models, Biological; Protein Kinase Inhibitors; Quinazolines; Recombinant Proteins; Young Adult | 2010 |